No Data
No Data
Half-year report for the year 2024.
Summary of Half-Year Report in 2024.
Australia Huazhong Endoscopy (688212.SH) released its performance for the first half of the year, with a net income of 5.6616 million yuan, a decrease of 85.13% compared to the same period last year.
Australian Chinese Endoscope (688212.SH) released its 2024 interim report, and the company achieved a revenue of 3...
Is The Market Rewarding Shanghai Aohua Photoelectricity Endoscope Co., Ltd. (SHSE:688212) With A Negative Sentiment As A Result Of Its Mixed Fundamentals?
Aohua Endoscopy (688212.SH): Shareholder Junlian Xinkang and concerted action parties completed a 1.5% shareholding reduction in the company.
Olympus (688212.SH) announced that as of the date of the announcement disclosure, the company's shareholder Suzhou Junlianxinkang entrepreneurial investment partnership ...
Shareholder Junlian Yikang and its concerted action have reduced their shareholding by a total of 1.42% in Aohua Endoscopy (688212.SH).
Auhua Endoscopy (688212.SH) announced that its shareholder, Peking Junlian Yikang Equity Investment Partnership (Limited Partnership) ...
No Data